Undifferentiated Ovarian Carcinoma (DBCOND0028876)

Identifiers

Synonyms

Ovarian Undifferentiated Carcinoma

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT01167712	Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer	Bevacizumab Carboplatin Paclitaxel	treatment	3	active_not_recruiting
NCT02446600	Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Carboplatin Cediranib Doxorubicin Gemcitabine Olaparib Paclitaxel Tetracycline	treatment	3	active_not_recruiting
NCT03641287	The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors	No drug interventions	supportive_care	Not Available	terminated
NCT01489371	EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Cholesterol Doxorubicin EGEN-001 Tetracycline	treatment	1	completed
NCT00888615	Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Elesclomol Paclitaxel	treatment	2	completed
NCT04092270	A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer	Benzalkonium Doxorubicin Nedisertib Tetracycline	treatment	1	recruiting
NCT00951496	Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Bevacizumab Carboplatin Chloride ion Cisplatin Paclitaxel Platinum	treatment	3	completed
NCT02923739	Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Bevacizumab Emactuzumab Paclitaxel	treatment	2	terminated
NCT01504126	Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	Propranolol	treatment	0	completed
NCT01097746	First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer	Bevacizumab Carboplatin Paclitaxel	treatment	2	completed
NCT00989651	Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer	Bevacizumab Carboplatin Chloride ion Cisplatin Paclitaxel Platinum Veliparib	treatment	1	completed
NCT00565851	Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer	Bevacizumab Carboplatin Docetaxel Gemcitabine Paclitaxel	treatment	3	active_not_recruiting
NCT00108745	Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer	Glutamic acid Paclitaxel Paclitaxel poliglumex	treatment	3	unknown_status
NCT02020707	Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers	Albumin human Bevacizumab Paclitaxel	treatment	1	completed
NCT02101775	Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	Adavosertib Gemcitabine	treatment	2	active_not_recruiting
NCT02364713	MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer	Bevacizumab Doxorubicin Gemcitabine Measles virus vaccine live attenuated Paclitaxel Sodium iodide Tetracycline Topotecan	treatment	2	active_not_recruiting
NCT02502266	Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer	Cediranib Doxorubicin Olaparib Paclitaxel Tetracycline Topotecan	treatment	2 / 3	active_not_recruiting
NCT02068794	MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer	Measles virus vaccine live attenuated Sodium iodide	treatment	1 / 2	active_not_recruiting
NCT00719303	Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	No drug interventions	prevention	3	unknown_status
NCT00004221	Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer	Carboplatin Cyclophosphamide Filgrastim Paclitaxel Topotecan	treatment	2	terminated
NCT01080521	Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy	No drug interventions	Not Available	Not Available	completed
NCT01074411	Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Bortezomib Bortezomib D-mannitol Carboplatin	treatment	1	completed
NCT00899093	YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy	No drug interventions	Not Available	Not Available	terminated
NCT01294293	TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer	Doxorubicin Motolimod Paclitaxel	treatment	1	completed
NCT00939809	A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Urokinase	treatment	2	completed
NCT02283658	Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer	Everolimus Letrozole	treatment	2	completed
NCT00814086	Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer	Cisplatin Paclitaxel	treatment	1	completed
NCT01459380	Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer	Bevacizumab Carboplatin Doxorubicin Tetracycline Veliparib	treatment	1	completed
NCT01275664	Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer	Aprepitant Carboplatin Chloride ion Cisplatin Dexamethasone Granisetron Platinum	supportive_care	Not Available	terminated
NCT00262847	Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer	Bevacizumab Carboplatin Paclitaxel	treatment	3	completed
NCT00060359	Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer	Carboplatin Glutamic acid Paclitaxel poliglumex	treatment	1	completed
NCT02853318	Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Bevacizumab Cyclophosphamide Pembrolizumab	treatment	2	completed
NCT02111941	Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer	Folic acid	treatment	0	active_not_recruiting